People with Down syndrome helped researchers discover breakthroughs in Alzheimer’s disease almost 40 years ago.
The Trial-Ready Cohort-Down Syndrome (TRC-DS) is a community of potential clinical trial participants who could help find a cure for Alzheimer’s disease.
As many as nine in 10 people with Down syndrome develop Alzheimer’s disease
There is no cure for Alzheimer’s disease. That’s why participants are needed to support new research into the connection between the two.
TRC-DS needs healthy adults with Down syndrome to advance therapies and potential cures
of 25 and 55 with Down syndrome to participate
Participants are needed
Researchers want to bring the most promising treatments to people with Down syndrome, but participants are needed.